Substance abuse relapse and factors associated with relapse in an inner-city sample of patients with dual diagnoses

Psychiatric Services

Volumn 56, Issue 10, 2005, Pages 1274-1281

  Rollins, Angela L ^a,b   O'Neill, Sheila J ^c   Davis, Kristin E ^c   Devitt, Timothy S ^c  

^a INDIANA UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Thresholds   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; COMORBIDITY; CONSUMER; DEMOGRAPHY; DISEASE SEVERITY; EMPLOYMENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; RELAPSE; REMISSION; REVIEW; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; URBAN AREA;

DEMOGRAPHY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DROPOUTS; PROGRAM EVALUATION; RECURRENCE; RESIDENTIAL TREATMENT; SUBSTANCE-RELATED DISORDERS; URBAN HEALTH SERVICES;

EID: 26044443052     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.56.10.1274     Document Type: Review

References (38)

1. Regier DA, Farmer ME, Rae DS, et al: Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264:2511-2518, 1990
2. Swofford CD, Kasckow JW, Scheller-Gilkey G, et al: Substance use: a powerful predictor of relapse in schizophrenia. Schizophrenia Research 20:145-151, 1996
3. Haywood TW, Kravitz HM, Grossman LS, et al: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective dis-orders. American Journal of Psychiatry 152:856-861, 1995
4. Beautrais AL, Joyce PR, Mulder RT, et al: Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. American Journal of Psychiatry 153:1009-1014, 1996
5. Rosenberg SD, Goodman LA, Osher FC, et al.: Prevaience of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health 91:31-37, 2001
6. Dickey B, Azeni H: Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. American Journal of Public Health 86: 973-977, 1996
7. Bailey LG, Maxwell S, Brandabur MM: Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients. Psychopharmacology Bulletin 33: 177-181, 1997
8. Abram KM, Teplin LA: Co-occurring disorders among mentally ill jail detainees: implications for public policy. American Psychologist 46:1036-1045, 1991
9. Cuffel BJ, Heithoff KA, Lawson W: Correlates of patterns of substance abuse among patients with schizophrenia. Hospital and Community Psychiatry 44:247-251, 1993
10. Goodman LA, Rosenberg SD, Mueser KT, et al: Physical and sexual assault history in women with serious mental illness: prevalence, correlates, treatment, and future research directions. Schizophrenia Bulletin 23:685-696, 1997
11. Drake RE, Mercer-McFadden C, Mueser KT, et al: Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin 24:589-608, 1998
12. Drake RE, Wallach MA: Substance abuse among the chronic mentally ill. Hospital and Community Psychiatry 40:1041-1046, 1989
13. Ridgely MS, Goldman HH, Willenbring M: Barriers to the care of persons with dual diagnoses: organizational and financing issues. Schizophrenia Bulletin 16:123-132, 1990
14. Drake RE, Mueser KT, Brunette MF, et al: A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal 27:360-374, 2004
15. McHugo GJ, Drake RE, Teague GB, et al: Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services 50:818-824, 1999
16. Miller WR, Rollnick S: Motivational Interviewing: Preparing People to Change Addictive behavior. New York, Guilford, 1991
17. Carey KB, Carey MP, Maisto SA, et al: The feasibility of enhancing psychiatric outpatients' readiness to change their substance use. Psychiatric Services 53:602-608, 2002
18. Carey KB, Purnine DM, Maisto SA, et al: Enhancing readiness-to-change substance abuse in persons with schizophrenia: a four-session motivation-based intervention. Behavior Modification 25:331-384, 2001
19. Alverson H, Alverson M, Drake RE: An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness. Community Mental Health Journal 36:557-569, 2000
20. Witkiewitz K, Marlatt GA: Relapse prevention for alcohol and drug problems: that was Zen, this is Tao. American Psychologist 59:224-235, 2004
21. Marlatt GA, George WH: Relapse prevention: introduction and overview of the model. British Journal of Addiction 79:261-273, 1984
22. Moos RH, Moos BS: Long-term influence of duration and frequency of participation in alcoholics anonymous on individuals with alcohol use disorders. Journal of Consulting and Clinical Psychology 72:81-90, 2004
23. McGovern MP, Wrisley BR, Drake RE: Relapse of substance use disorder and its prevention among persons with co-occurring disorders. Psychiatric Services 56:1270-1273, 2005
24. Xie H, McHugo GJ, Fox MB, et al: Substance abuse relapse in a ten-year prospective follow-up of clients with severe mental and substance use disorders. Psychiatric Services 56:1282-1287, 2005
25. Mueser KT, Drake RE, Clark RE, et al: Toolkit for Evaluating Substance Abuse in Persons With Severe Mental Illness. Cambridge, Mass, Evaluation Center at Human Services Research Institute, 1995
26. Drake RE, Osher FC, Noordsy DL, et al: Diagnosis of alcohol use disorders in schizophrenia. Schizophrenia Bulletin 16:57-67, 1990
27. McHugo GJ, Drake RE, Burton HL, et al: A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease 183:762-767, 1995
28. Drake RE, McHugo GJ, Clark RE, et al: Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry 68: 201-215, 1998
29. Barker S, Barron N, McFarland BH, et al: A community ability scale for chronically mentally ill consumers: I. reliability and validity. Community Mental Health Journal 30:363-383, 1994
30. Barker S, Barren N, McFarland BH, et al: A community ability scale for chronically mentally ill consumers: II. applications. Community Mental Health Journal 30: 459-472, 1994
31. Warner LA, Kessler RC, Hughes M, et al: Prevalence and correlates of drug use and dependence in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 52:219-229, 1995
32. Mueser KT, Yarnold PR, Rosenberg SD, et al: Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophrenia Bulletin 26:179-192, 2000
33. Mueser KT, Yarnold PR, Levinson DF, et al: Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophrenia Bulletin 16:31-56, 1990
34. Warner R: The Environment of Schizophrenia: Innovations in Practice, Policy, and Communications. Philadelphia, Taylor and Francis, 2000
35. McCoy ML, Devitt T, Clay R, et al: Gaining insight: who benefits from residential, integrated treatment for people with dual diagnoses? Psychiatric Rehabilitation Journal 27:140-150, 2003
36. Brunette MF, Mueser KT, Drake RE: A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review 23:471-481, 2004
37. Goldfinger SM, Schutt RK, Toloiniczenko GS, et al: Housing placement and subsequent days homeless among formerly homeless adults with mental illness. Psychiatric Services 50:674-679, 1999
38. Tsemberis S, Eisenberg RF: Pathways to housing: supported housing for street-dwelling homeless individuals with psychiatric disabilities. Psychiatric Services 51: 487-493, 2000